by Warren A. Kaplan, Paul G. Ashigbie, Mohamad I. Brooks et al.
Journal of Pharmaceutical Policy and Practice, 2017 10:17 – Published: 16 May 2017
Many middle-income countries are scaling up health insurance schemes to provide financial protection and access to affordable medicines to poor and uninsured populations. Although there is a wealth of evidence on how high income countries with mature insurance schemes manage cost-effective use of medicines, there is limited evidence on the strategies used in middle-income countries. This paper compares the medicines management strategies that four insurance schemes in middle-income countries use to improve access and cost-effective use of medicines among beneficiaries.